Investors

Insider Transactions

Date Name Sorted Descending Title Type Shares Traded Price Range
Aug 28, 2008 roberts william Officer Acquisition (Non Open Market) 8,106 n/a
Aug 22, 2008 roberts william Officer Disposition (Non Open Market) 24,102 n/a
Aug 22, 2008 roberts william Officer Acquisition (Non Open Market) 24,102 n/a
Aug 20, 2008 roberts william Officer Option Execute 34,840 6.50
Aug 20, 2008 roberts william Officer Disposition (Non Open Market) 10,582 21.40
Nov 20, 2007 roberts william Officer Acquisition (Non Open Market) 34,684 n/a
Jan 2, 2014 powchik peter Officer Automatic Sell 20,668 272.88 - 277.50
Dec 31, 2013 powchik peter Officer Option Execute 48,000 30.63
Dec 31, 2013 powchik peter Officer Automatic Sell 27,332 276.09
Dec 24, 2013 powchik peter Officer Option Execute 4,705 21.25
Dec 20, 2013 powchik peter Officer Automatic Sell 133 271.09
Dec 18, 2013 powchik peter Officer Option Execute 295 21.25
Dec 18, 2013 powchik peter Officer Automatic Sell 9,162 264.86 - 270.20
Dec 17, 2013 powchik peter Officer Automatic Sell 8 270.00
Dec 16, 2013 powchik peter Officer Option Execute 30,625 30.63 - 179.13
Dec 16, 2013 powchik peter Officer Automatic Sell 21,617 272.73
Jan 9, 2013 powchik peter Officer Option Execute 5,752 16.80 - 21.25
Jan 3, 2013 powchik peter Officer Automatic Sell 13,586 180.83 - 183.10
Jan 2, 2013 powchik peter Officer Option Execute 30,000 21.25
Jan 2, 2013 powchik peter Officer Automatic Sell 16,414 177.82
Showing 401-420 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)